ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation Meeting Abstract
| Authors: | Stivala, S.; Baerenwaldt, A.; Codilupi, T.; Ghosh, N.; Hao-Shen, H.; Dirnhofer, S.; Dettmer, M. S.; Simillion, C.; Chiu, S.; Keller, M.; Kleppe, M.; Hilpert, M.; Buser, A.; Passweg, J. R.; Radimerski, T.; Skoda, R. C.; Levine, R. L.; Meyer, S. C. |
| Abstract Title: | ERK and MEK kinases as novel therapeutic targets in myeloproliferative neoplasms based on bypass MAPK pathway activation |
| Meeting Title: | 1st Swiss Oncology & Hematology Congress (SOHC 2018) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 148 |
| Issue: | Suppl. 230 |
| Meeting Dates: | 2018 Jun 27-29 |
| Meeting Location: | Zurich, Switzerland |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2018-06-27 |
| Start Page: | 28S |
| Language: | English |
| ACCESSION: | WOS:000447724400088 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
